Literature DB >> 2424500

Covalent linkage of phospholipid to myelin basic protein: identification of serine-54 as the site of attachment.

P C Chang, J C Yang, J M Fujitaki, K C Chiu, R A Smith.   

Abstract

The peptide portion of the lipopeptide isolated from bovine myelin basic protein contained glycine, lysine, and serine in a 2:1:1 molar ratio as determined by amino acid analysis. The N-terminus of the peptide was determined to be glycine. The tetrapeptide Gly53-Ser-Gly-Lys56 was the only segment of myelin basic protein that matched the above two characteristics. This tetrapeptide is highly conserved among the myelin basic proteins sequenced so far. After the selective degradation of the lipopeptide, phosphoserine was identified in the acid hydrolysate, thus indicating that Ser-54 of myelin basic protein in bovine brain is the site of attachment of polyphosphoinositide. Interestingly, serine-54 of myelin basic protein can be phosphorylated by the endogenous protein kinase myelin. However, myelin basic protein phosphorylated by the catalytic subunit of an exogenous soluble protein kinase failed to produce radioactively labeled lipopeptide. Hence the endogenous enzymes of myelin are thought to be involved in the formation of the covalent linkage between polyphosphoinositide and myelin basic protein. The conservation in sequence suggests a possible important structural role for the "phospholipidation" of myelin basic protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424500     DOI: 10.1021/bi00357a059

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Direct measurement of inositol in bovine myelin basic protein.

Authors:  R Smith; P E Braun; M A Ferguson; M G Low; W R Sherman
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

2.  In vivo labeling of myelin lipids and proteolipid protein with [3H]myristate, [14C]linoleate, and [14C]linolenate.

Authors:  P Bürgisser; J M Matthieu
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.